Haemonetics Corp. buy Citigroup Inc.
Start price
09.07.25
/
50%
€65.00
Target price
09.07.26
€76.78
Performance (%)
-33.54%
Price
08.10.25
€43.00
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Haemonetics Corp. is performing very badly with a performance of -33.54%. This prediction currently runs until 09.07.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.911% | 5.911% |
| iShares Core DAX® | 1.644% | 3.553% |
| iShares Nasdaq 100 | 2.211% | 6.941% |
| iShares Nikkei 225® | 3.718% | 6.703% |
| iShares S&P 500 | 1.557% | 5.211% |
Comments by Citigroup_Inc_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock.
Ratings data for HAE provided by MarketBeat